Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2122)
IONIS PHARMACEUTICALS INC (IONS)
Diaz Allene M. — Director
Shares
1,005
Price
$80.80
Total Value
$81.20K
Shares Held After
3,811
% of Holdings
20.9%
IONIS PHARMACEUTICALS INC (IONS)
Diaz Allene M. — Director
Shares
14,608
Price
$79.88
Total Value
$1.17M
Shares Held After
4,816
% of Holdings
75.2%
IONIS PHARMACEUTICALS INC (IONS)
Diaz Allene M. — Director
Shares
39,265
Price
$79.11
Total Value
$3.11M
Shares Held After
19,424
% of Holdings
66.9%
BIOLIFE SOLUTIONS INC (BLFS)
Foster Karen A. — Chief Quality and Operations
Shares
418
Price
$20.74
Total Value
$8.67K
Shares Held After
210,665
% of Holdings
0.2%
Zai Lab Ltd (ZLAB)
Amado Rafael — President, Head of Global Oncology Research and Development
Shares
10,000
Price
$17.38
Total Value
$173.80K
Shares Held After
42,391
% of Holdings
19.1%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
36
Price
$81.01
Total Value
$2.92K
Shares Held After
4,347
% of Holdings
0.8%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
2,088
Price
$80.41
Total Value
$167.89K
Shares Held After
4,383
% of Holdings
32.3%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
4,096
Price
$79.36
Total Value
$325.06K
Shares Held After
41,317
% of Holdings
9.0%
BIOLIFE SOLUTIONS INC (BLFS)
Mathew Aby J. — EVP & Chief Scientific Officer
Shares
529
Price
$20.74
Total Value
$10.97K
Shares Held After
392,937
% of Holdings
0.1%
BIOLIFE SOLUTIONS INC (BLFS)
Aebersold Sarah — Chief Human Resources Officer
Shares
219
Price
$20.74
Total Value
$4.54K
Shares Held After
93,360
% of Holdings
0.2%
IONIS PHARMACEUTICALS INC (IONS)
LOSCALZO JOSEPH — Director
Shares
832
Price
$80.33
Total Value
$66.83K
Shares Held After
36,330
% of Holdings
2.2%
NovoCure Limited (NVCR)
DOYLE WILLIAM F — Director
Shares
21,330
Price
$13.43
Total Value
$286.44K
Shares Held After
328,397
% of Holdings
6.1%
NovoCure Limited (NVCR)
DOYLE WILLIAM F — Director
Shares
50,557
Price
$12.79
Total Value
$646.45K
Shares Held After
349,727
% of Holdings
12.6%
INTUITIVE SURGICAL INC (ISRG)
Brosius Mark — SVP & Chief Mfg and Supply Cha
Shares
648
Price
$488.10
Total Value
$316.29K
Shares Held After
5,916
% of Holdings
9.9%
BIOLIFE SOLUTIONS INC (BLFS)
Werner Sean — Chief Technology Officer
Shares
111
Price
$20.74
Total Value
$2.30K
Shares Held After
49,932
% of Holdings
0.2%
Doximity, Inc. (DOCS)
Wampler Kira Scherer — Director
Shares
2,000
Price
$26.00
Total Value
$52.00K
Shares Held After
19,839
% of Holdings
9.2%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
755
Price
$80.84
Total Value
$61.03K
Shares Held After
22,541
% of Holdings
3.2%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
5,030
Price
$80.00
Total Value
$402.39K
Shares Held After
23,296
% of Holdings
17.8%
IONIS PHARMACEUTICALS INC (IONS)
Devers Shannon L. — EVP, Chief Human Resources Ofc
Shares
14,321
Price
$79.11
Total Value
$1.13M
Shares Held After
28,326
% of Holdings
33.6%
Bausch & Lomb Corp (BLCO)
Ross Thomas W. Sr. — Director
Shares
4,500
Price
$17.68
Total Value
$79.56K
Shares Held After
64,891
% of Holdings
6.9%
Editas Medicine, Inc. (EDIT)
Burkly Linda — EVP, CHIEF SCIENTIFIC OFFICER
Shares
749
Price
$2.02
Total Value
$1.51K
Shares Held After
68,028
% of Holdings
1.1%
Butterfly Network, Inc. (BFLY)
Caezza Nicholas — Deputy General Counsel
Shares
14,209
Price
$3.71
Total Value
$52.74K
Shares Held After
312,040
% of Holdings
4.4%
Editas Medicine, Inc. (EDIT)
Parison Amy — SVP, Chief Financial Officer
Shares
474
Price
$2.02
Total Value
$957.48
Shares Held After
15,434
% of Holdings
3.0%
ARTIVION, INC. (AORT)
Stanton Marshall S. — SVP, Clinical & MD Affair
Shares
2,149
Price
$37.78
Total Value
$81.18K
Shares Held After
60,097
% of Holdings
3.5%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$29.76
Total Value
$60.53K
Shares Held After
235,626
% of Holdings
0.9%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
233
Price
$187.84
Total Value
$43.77K
Shares Held After
405,796
% of Holdings
0.1%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
2,608
Price
$186.73
Total Value
$487.00K
Shares Held After
406,029
% of Holdings
0.6%
Jazz Pharmaceuticals plc (JAZZ)
COZADD BRUCE C — Director
Shares
3,159
Price
$186.09
Total Value
$587.84K
Shares Held After
408,637
% of Holdings
0.8%
ANI PHARMACEUTICALS INC (ANIP)
Gutwerg Ori — SVP, GENERICS
Shares
2,060
Price
$76.50
Total Value
$157.59K
Shares Held After
84,782
% of Holdings
2.4%
ARTIVION, INC. (AORT)
Mackin James P — President & CEO
Shares
17,887
Price
$37.78
Total Value
$675.69K
Shares Held After
947,275
% of Holdings
1.9%
Editas Medicine, Inc. (EDIT)
O'Neill Gilmore Neil — Director
Shares
5,394
Price
$2.02
Total Value
$10.89K
Shares Held After
263,693
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
1,635
Price
$22.40
Total Value
$36.62K
Shares Held After
85,034
% of Holdings
1.9%
INTUITIVE SURGICAL INC (ISRG)
Widman Fredrik — VP Corporate Controller
Shares
118
Price
$487.18
Total Value
$57.49K
Shares Held After
1,026
% of Holdings
10.3%
Olema Pharmaceuticals, Inc. (OLMA)
Mitchell Shawnte — CHIEF LEGAL OFFICER
Shares
15,000
Price
$23.01
Total Value
$345.15K
Shares Held After
0
% of Holdings
100.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
6,518
Price
$16.33
Total Value
$106.44K
Shares Held After
583,911
% of Holdings
1.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
24,423
Price
$15.49
Total Value
$378.31K
Shares Held After
590,429
% of Holdings
4.0%
Adaptive Biotechnologies Corp (ADPT)
GRIFFIN MICHELLE RENEE — Director
Shares
48,044
Price
$15.30
Total Value
$735.07K
Shares Held After
15,394
% of Holdings
75.7%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
13,555
Price
$18.22
Total Value
$246.91K
Shares Held After
145,355
% of Holdings
8.5%
Bicara Therapeutics Inc. (BCAX)
Raben David — Chief Medical Officer
Shares
200
Price
$18.45
Total Value
$3.69K
Shares Held After
55,286
% of Holdings
0.4%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
4,500
Price
$18.16
Total Value
$81.73K
Shares Held After
205,141
% of Holdings
2.1%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
12,892
Price
$18.16
Total Value
$234.16K
Shares Held After
209,641
% of Holdings
5.8%
AN2 Therapeutics, Inc. (ANTX)
Williams Sarah Joanne — Principal Accounting Officer
Shares
327
Price
$1.06
Total Value
$346.62
Shares Held After
66,848
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
421
Price
$507.09
Total Value
$213.49K
Shares Held After
130
% of Holdings
76.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
132
Price
$506.16
Total Value
$66.81K
Shares Held After
551
% of Holdings
19.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
908
Price
$505.06
Total Value
$458.59K
Shares Held After
683
% of Holdings
57.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
730
Price
$503.99
Total Value
$367.91K
Shares Held After
1,591
% of Holdings
31.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
210
Price
$503.03
Total Value
$105.64K
Shares Held After
2,321
% of Holdings
8.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
379
Price
$501.93
Total Value
$190.23K
Shares Held After
2,531
% of Holdings
13.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
495
Price
$500.96
Total Value
$247.98K
Shares Held After
2,910
% of Holdings
14.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,058
Price
$499.85
Total Value
$528.85K
Shares Held After
3,405
% of Holdings
23.7%
Showing 1351–1400 of 2122 transactions (page 28 of 43)